Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-11

Clinical Trial Update: Safety Study of Inactivated Shigella Whole Cell Vaccine in Adults [Phase 1]

View source ↗

Summary

Phase 1 safety study of an inactivated Shigella whole cell vaccine completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Inactivated Shigella Whole Cell Vaccine

Snippet

Sponsor: PATH | Conditions: Shigellosis | Phase 1 | Status: COMPLETED | Results posted: 2021-08-11